Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
capsid
Biotech
AbbVie pays $70M to expand Capsida collab into eye disease
Capsida is diving into the world of eye disease with AbbVie, inking a new pact for three new gene medicine targets.
Gabrielle Masson
Feb 23, 2023 5:00am
Novartis eyes next-gen AAV therapies in $1.75B Voyager pact
Mar 8, 2022 1:15am
Novartis, Sarepta tap Dyno to unearth new gene therapy vectors
May 11, 2020 7:00am
Passage Bio adds more programs, tech and time to UPenn deal
May 7, 2020 7:30am
Taysha debuts with $30M, 15 gene therapy programs
Apr 29, 2020 8:00am
Sarepta pays StrideBio $48M for preclinical gene therapies
Nov 15, 2019 8:15am
